[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Intranasal Vaccine Supply, Demand and Key Producers, 2023-2029

June 2023 | 108 pages | ID: G8D16DDB59D5EN
GlobalInfoResearch

US$ 4,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Intranasal Vaccine market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Vaccines administered nasally

This report studies the global Intranasal Vaccine production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Intranasal Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Intranasal Vaccine that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Intranasal Vaccine total production and demand, 2018-2029, (K Units)

Global Intranasal Vaccine total production value, 2018-2029, (USD Million)

Global Intranasal Vaccine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Intranasal Vaccine consumption by region & country, CAGR, 2018-2029 & (K Units)

U.S. VS China: Intranasal Vaccine domestic production, consumption, key domestic manufacturers and share

Global Intranasal Vaccine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)

Global Intranasal Vaccine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Intranasal Vaccine production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)

This reports profiles key players in the global Intranasal Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, AstraZeneca, Abbott, GlaxoSmithKline, Serum Institute of India, Bharat Biotech, Antares Pharma, INJEX Pharma GmbH and BioDiem, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Intranasal Vaccine market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Intranasal Vaccine Market, By Region:
  • United States
  • China
  • Europe
  • Japan
  • South Korea
  • ASEAN
  • India
  • Rest of World
Global Intranasal Vaccine Market, Segmentation by Type
  • Flu Vaccine
  • COVID-19 Vaccines
Global Intranasal Vaccine Market, Segmentation by Application
  • Hospital
  • Clinic
Companies Profiled:
  • Sanofi
  • AstraZeneca
  • Abbott
  • GlaxoSmithKline
  • Serum Institute of India
  • Bharat Biotech
  • Antares Pharma
  • INJEX Pharma GmbH
  • BioDiem
  • PharmaJet and Crossject
  • Beijing Wantai Biopharmaceutical Co., Ltd.
Key Questions Answered

1. How big is the global Intranasal Vaccine market?

2. What is the demand of the global Intranasal Vaccine market?

3. What is the year over year growth of the global Intranasal Vaccine market?

4. What is the production and production value of the global Intranasal Vaccine market?

5. Who are the key producers in the global Intranasal Vaccine market?

6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY

1.1 Intranasal Vaccine Introduction
1.2 World Intranasal Vaccine Supply & Forecast
  1.2.1 World Intranasal Vaccine Production Value (2018 & 2022 & 2029)
  1.2.2 World Intranasal Vaccine Production (2018-2029)
  1.2.3 World Intranasal Vaccine Pricing Trends (2018-2029)
1.3 World Intranasal Vaccine Production by Region (Based on Production Site)
  1.3.1 World Intranasal Vaccine Production Value by Region (2018-2029)
  1.3.2 World Intranasal Vaccine Production by Region (2018-2029)
  1.3.3 World Intranasal Vaccine Average Price by Region (2018-2029)
  1.3.4 North America Intranasal Vaccine Production (2018-2029)
  1.3.5 Europe Intranasal Vaccine Production (2018-2029)
  1.3.6 China Intranasal Vaccine Production (2018-2029)
  1.3.7 Japan Intranasal Vaccine Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Intranasal Vaccine Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Intranasal Vaccine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
  1.5.1 Influence of COVID-19
  1.5.2 Influence of Russia-Ukraine War

2 DEMAND SUMMARY

2.1 World Intranasal Vaccine Demand (2018-2029)
2.2 World Intranasal Vaccine Consumption by Region
  2.2.1 World Intranasal Vaccine Consumption by Region (2018-2023)
  2.2.2 World Intranasal Vaccine Consumption Forecast by Region (2024-2029)
2.3 United States Intranasal Vaccine Consumption (2018-2029)
2.4 China Intranasal Vaccine Consumption (2018-2029)
2.5 Europe Intranasal Vaccine Consumption (2018-2029)
2.6 Japan Intranasal Vaccine Consumption (2018-2029)
2.7 South Korea Intranasal Vaccine Consumption (2018-2029)
2.8 ASEAN Intranasal Vaccine Consumption (2018-2029)
2.9 India Intranasal Vaccine Consumption (2018-2029)

3 WORLD INTRANASAL VACCINE MANUFACTURERS COMPETITIVE ANALYSIS

3.1 World Intranasal Vaccine Production Value by Manufacturer (2018-2023)
3.2 World Intranasal Vaccine Production by Manufacturer (2018-2023)
3.3 World Intranasal Vaccine Average Price by Manufacturer (2018-2023)
3.4 Intranasal Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
  3.5.1 Global Intranasal Vaccine Industry Rank of Major Manufacturers
  3.5.2 Global Concentration Ratios (CR4) for Intranasal Vaccine in 2022
  3.5.3 Global Concentration Ratios (CR8) for Intranasal Vaccine in 2022
3.6 Intranasal Vaccine Market: Overall Company Footprint Analysis
  3.6.1 Intranasal Vaccine Market: Region Footprint
  3.6.2 Intranasal Vaccine Market: Company Product Type Footprint
  3.6.3 Intranasal Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
  3.7.1 Historical Structure of the Industry
  3.7.2 Barriers of Market Entry
  3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 UNITED STATES VS CHINA VS REST OF THE WORLD

4.1 United States VS China: Intranasal Vaccine Production Value Comparison
  4.1.1 United States VS China: Intranasal Vaccine Production Value Comparison (2018 & 2022 & 2029)
  4.1.2 United States VS China: Intranasal Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Intranasal Vaccine Production Comparison
  4.2.1 United States VS China: Intranasal Vaccine Production Comparison (2018 & 2022 & 2029)
  4.2.2 United States VS China: Intranasal Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Intranasal Vaccine Consumption Comparison
  4.3.1 United States VS China: Intranasal Vaccine Consumption Comparison (2018 & 2022 & 2029)
  4.3.2 United States VS China: Intranasal Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Intranasal Vaccine Manufacturers and Market Share, 2018-2023
  4.4.1 United States Based Intranasal Vaccine Manufacturers, Headquarters and Production Site (States, Country)
  4.4.2 United States Based Manufacturers Intranasal Vaccine Production Value (2018-2023)
  4.4.3 United States Based Manufacturers Intranasal Vaccine Production (2018-2023)
4.5 China Based Intranasal Vaccine Manufacturers and Market Share
  4.5.1 China Based Intranasal Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
  4.5.2 China Based Manufacturers Intranasal Vaccine Production Value (2018-2023)
  4.5.3 China Based Manufacturers Intranasal Vaccine Production (2018-2023)
4.6 Rest of World Based Intranasal Vaccine Manufacturers and Market Share, 2018-2023
  4.6.1 Rest of World Based Intranasal Vaccine Manufacturers, Headquarters and Production Site (State, Country)
  4.6.2 Rest of World Based Manufacturers Intranasal Vaccine Production Value (2018-2023)
  4.6.3 Rest of World Based Manufacturers Intranasal Vaccine Production (2018-2023)

5 MARKET ANALYSIS BY TYPE

5.1 World Intranasal Vaccine Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
  5.2.1 Flu Vaccine
  5.2.2 COVID-19 Vaccines
5.3 Market Segment by Type
  5.3.1 World Intranasal Vaccine Production by Type (2018-2029)
  5.3.2 World Intranasal Vaccine Production Value by Type (2018-2029)
  5.3.3 World Intranasal Vaccine Average Price by Type (2018-2029)

6 MARKET ANALYSIS BY APPLICATION

6.1 World Intranasal Vaccine Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
  6.2.1 Hospital
  6.2.2 Clinic
6.3 Market Segment by Application
  6.3.1 World Intranasal Vaccine Production by Application (2018-2029)
  6.3.2 World Intranasal Vaccine Production Value by Application (2018-2029)
  6.3.3 World Intranasal Vaccine Average Price by Application (2018-2029)

7 COMPANY PROFILES

7.1 Sanofi
  7.1.1 Sanofi Details
  7.1.2 Sanofi Major Business
  7.1.3 Sanofi Intranasal Vaccine Product and Services
  7.1.4 Sanofi Intranasal Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.1.5 Sanofi Recent Developments/Updates
  7.1.6 Sanofi Competitive Strengths & Weaknesses
7.2 AstraZeneca
  7.2.1 AstraZeneca Details
  7.2.2 AstraZeneca Major Business
  7.2.3 AstraZeneca Intranasal Vaccine Product and Services
  7.2.4 AstraZeneca Intranasal Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.2.5 AstraZeneca Recent Developments/Updates
  7.2.6 AstraZeneca Competitive Strengths & Weaknesses
7.3 Abbott
  7.3.1 Abbott Details
  7.3.2 Abbott Major Business
  7.3.3 Abbott Intranasal Vaccine Product and Services
  7.3.4 Abbott Intranasal Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.3.5 Abbott Recent Developments/Updates
  7.3.6 Abbott Competitive Strengths & Weaknesses
7.4 GlaxoSmithKline
  7.4.1 GlaxoSmithKline Details
  7.4.2 GlaxoSmithKline Major Business
  7.4.3 GlaxoSmithKline Intranasal Vaccine Product and Services
  7.4.4 GlaxoSmithKline Intranasal Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.4.5 GlaxoSmithKline Recent Developments/Updates
  7.4.6 GlaxoSmithKline Competitive Strengths & Weaknesses
7.5 Serum Institute of India
  7.5.1 Serum Institute of India Details
  7.5.2 Serum Institute of India Major Business
  7.5.3 Serum Institute of India Intranasal Vaccine Product and Services
  7.5.4 Serum Institute of India Intranasal Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.5.5 Serum Institute of India Recent Developments/Updates
  7.5.6 Serum Institute of India Competitive Strengths & Weaknesses
7.6 Bharat Biotech
  7.6.1 Bharat Biotech Details
  7.6.2 Bharat Biotech Major Business
  7.6.3 Bharat Biotech Intranasal Vaccine Product and Services
  7.6.4 Bharat Biotech Intranasal Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.6.5 Bharat Biotech Recent Developments/Updates
  7.6.6 Bharat Biotech Competitive Strengths & Weaknesses
7.7 Antares Pharma
  7.7.1 Antares Pharma Details
  7.7.2 Antares Pharma Major Business
  7.7.3 Antares Pharma Intranasal Vaccine Product and Services
  7.7.4 Antares Pharma Intranasal Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.7.5 Antares Pharma Recent Developments/Updates
  7.7.6 Antares Pharma Competitive Strengths & Weaknesses
7.8 INJEX Pharma GmbH
  7.8.1 INJEX Pharma GmbH Details
  7.8.2 INJEX Pharma GmbH Major Business
  7.8.3 INJEX Pharma GmbH Intranasal Vaccine Product and Services
  7.8.4 INJEX Pharma GmbH Intranasal Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.8.5 INJEX Pharma GmbH Recent Developments/Updates
  7.8.6 INJEX Pharma GmbH Competitive Strengths & Weaknesses
7.9 BioDiem
  7.9.1 BioDiem Details
  7.9.2 BioDiem Major Business
  7.9.3 BioDiem Intranasal Vaccine Product and Services
  7.9.4 BioDiem Intranasal Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.9.5 BioDiem Recent Developments/Updates
  7.9.6 BioDiem Competitive Strengths & Weaknesses
7.10 PharmaJet and Crossject
  7.10.1 PharmaJet and Crossject Details
  7.10.2 PharmaJet and Crossject Major Business
  7.10.3 PharmaJet and Crossject Intranasal Vaccine Product and Services
  7.10.4 PharmaJet and Crossject Intranasal Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.10.5 PharmaJet and Crossject Recent Developments/Updates
  7.10.6 PharmaJet and Crossject Competitive Strengths & Weaknesses
7.11 Beijing Wantai Biopharmaceutical Co., Ltd.
  7.11.1 Beijing Wantai Biopharmaceutical Co., Ltd. Details
  7.11.2 Beijing Wantai Biopharmaceutical Co., Ltd. Major Business
  7.11.3 Beijing Wantai Biopharmaceutical Co., Ltd. Intranasal Vaccine Product and Services
  7.11.4 Beijing Wantai Biopharmaceutical Co., Ltd. Intranasal Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.11.5 Beijing Wantai Biopharmaceutical Co., Ltd. Recent Developments/Updates
  7.11.6 Beijing Wantai Biopharmaceutical Co., Ltd. Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 Intranasal Vaccine Industry Chain
8.2 Intranasal Vaccine Upstream Analysis
  8.2.1 Intranasal Vaccine Core Raw Materials
  8.2.2 Main Manufacturers of Intranasal Vaccine Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Intranasal Vaccine Production Mode
8.6 Intranasal Vaccine Procurement Model
8.7 Intranasal Vaccine Industry Sales Model and Sales Channels
  8.7.1 Intranasal Vaccine Sales Model
  8.7.2 Intranasal Vaccine Typical Customers

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

LIST OF TABLES

Table 1. World Intranasal Vaccine Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Intranasal Vaccine Production Value by Region (2018-2023) & (USD Million)
Table 3. World Intranasal Vaccine Production Value by Region (2024-2029) & (USD Million)
Table 4. World Intranasal Vaccine Production Value Market Share by Region (2018-2023)
Table 5. World Intranasal Vaccine Production Value Market Share by Region (2024-2029)
Table 6. World Intranasal Vaccine Production by Region (2018-2023) & (K Units)
Table 7. World Intranasal Vaccine Production by Region (2024-2029) & (K Units)
Table 8. World Intranasal Vaccine Production Market Share by Region (2018-2023)
Table 9. World Intranasal Vaccine Production Market Share by Region (2024-2029)
Table 10. World Intranasal Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Intranasal Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Intranasal Vaccine Major Market Trends
Table 13. World Intranasal Vaccine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Intranasal Vaccine Consumption by Region (2018-2023) & (K Units)
Table 15. World Intranasal Vaccine Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Intranasal Vaccine Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Intranasal Vaccine Producers in 2022
Table 18. World Intranasal Vaccine Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Intranasal Vaccine Producers in 2022
Table 20. World Intranasal Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Intranasal Vaccine Company Evaluation Quadrant
Table 22. World Intranasal Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Intranasal Vaccine Production Site of Key Manufacturer
Table 24. Intranasal Vaccine Market: Company Product Type Footprint
Table 25. Intranasal Vaccine Market: Company Product Application Footprint
Table 26. Intranasal Vaccine Competitive Factors
Table 27. Intranasal Vaccine New Entrant and Capacity Expansion Plans
Table 28. Intranasal Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Intranasal Vaccine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Intranasal Vaccine Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Intranasal Vaccine Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Intranasal Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Intranasal Vaccine Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Intranasal Vaccine Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Intranasal Vaccine Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Intranasal Vaccine Production Market Share (2018-2023)
Table 37. China Based Intranasal Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Intranasal Vaccine Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Intranasal Vaccine Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Intranasal Vaccine Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Intranasal Vaccine Production Market Share (2018-2023)
Table 42. Rest of World Based Intranasal Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Intranasal Vaccine Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Intranasal Vaccine Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Intranasal Vaccine Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Intranasal Vaccine Production Market Share (2018-2023)
Table 47. World Intranasal Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Intranasal Vaccine Production by Type (2018-2023) & (K Units)
Table 49. World Intranasal Vaccine Production by Type (2024-2029) & (K Units)
Table 50. World Intranasal Vaccine Production Value by Type (2018-2023) & (USD Million)
Table 51. World Intranasal Vaccine Production Value by Type (2024-2029) & (USD Million)
Table 52. World Intranasal Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Intranasal Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Intranasal Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Intranasal Vaccine Production by Application (2018-2023) & (K Units)
Table 56. World Intranasal Vaccine Production by Application (2024-2029) & (K Units)
Table 57. World Intranasal Vaccine Production Value by Application (2018-2023) & (USD Million)
Table 58. World Intranasal Vaccine Production Value by Application (2024-2029) & (USD Million)
Table 59. World Intranasal Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Intranasal Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Sanofi Basic Information, Manufacturing Base and Competitors
Table 62. Sanofi Major Business
Table 63. Sanofi Intranasal Vaccine Product and Services
Table 64. Sanofi Intranasal Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Sanofi Recent Developments/Updates
Table 66. Sanofi Competitive Strengths & Weaknesses
Table 67. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 68. AstraZeneca Major Business
Table 69. AstraZeneca Intranasal Vaccine Product and Services
Table 70. AstraZeneca Intranasal Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. AstraZeneca Recent Developments/Updates
Table 72. AstraZeneca Competitive Strengths & Weaknesses
Table 73. Abbott Basic Information, Manufacturing Base and Competitors
Table 74. Abbott Major Business
Table 75. Abbott Intranasal Vaccine Product and Services
Table 76. Abbott Intranasal Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Abbott Recent Developments/Updates
Table 78. Abbott Competitive Strengths & Weaknesses
Table 79. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 80. GlaxoSmithKline Major Business
Table 81. GlaxoSmithKline Intranasal Vaccine Product and Services
Table 82. GlaxoSmithKline Intranasal Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. GlaxoSmithKline Recent Developments/Updates
Table 84. GlaxoSmithKline Competitive Strengths & Weaknesses
Table 85. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 86. Serum Institute of India Major Business
Table 87. Serum Institute of India Intranasal Vaccine Product and Services
Table 88. Serum Institute of India Intranasal Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Serum Institute of India Recent Developments/Updates
Table 90. Serum Institute of India Competitive Strengths & Weaknesses
Table 91. Bharat Biotech Basic Information, Manufacturing Base and Competitors
Table 92. Bharat Biotech Major Business
Table 93. Bharat Biotech Intranasal Vaccine Product and Services
Table 94. Bharat Biotech Intranasal Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Bharat Biotech Recent Developments/Updates
Table 96. Bharat Biotech Competitive Strengths & Weaknesses
Table 97. Antares Pharma Basic Information, Manufacturing Base and Competitors
Table 98. Antares Pharma Major Business
Table 99. Antares Pharma Intranasal Vaccine Product and Services
Table 100. Antares Pharma Intranasal Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Antares Pharma Recent Developments/Updates
Table 102. Antares Pharma Competitive Strengths & Weaknesses
Table 103. INJEX Pharma GmbH Basic Information, Manufacturing Base and Competitors
Table 104. INJEX Pharma GmbH Major Business
Table 105. INJEX Pharma GmbH Intranasal Vaccine Product and Services
Table 106. INJEX Pharma GmbH Intranasal Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. INJEX Pharma GmbH Recent Developments/Updates
Table 108. INJEX Pharma GmbH Competitive Strengths & Weaknesses
Table 109. BioDiem Basic Information, Manufacturing Base and Competitors
Table 110. BioDiem Major Business
Table 111. BioDiem Intranasal Vaccine Product and Services
Table 112. BioDiem Intranasal Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. BioDiem Recent Developments/Updates
Table 114. BioDiem Competitive Strengths & Weaknesses
Table 115. PharmaJet and Crossject Basic Information, Manufacturing Base and Competitors
Table 116. PharmaJet and Crossject Major Business
Table 117. PharmaJet and Crossject Intranasal Vaccine Product and Services
Table 118. PharmaJet and Crossject Intranasal Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. PharmaJet and Crossject Recent Developments/Updates
Table 120. Beijing Wantai Biopharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 121. Beijing Wantai Biopharmaceutical Co., Ltd. Major Business
Table 122. Beijing Wantai Biopharmaceutical Co., Ltd. Intranasal Vaccine Product and Services
Table 123. Beijing Wantai Biopharmaceutical Co., Ltd. Intranasal Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 124. Global Key Players of Intranasal Vaccine Upstream (Raw Materials)
Table 125. Intranasal Vaccine Typical Customers
Table 126. Intranasal Vaccine Typical Distributors

LIST OF FIGURES

Figure 1. Intranasal Vaccine Picture
Figure 2. World Intranasal Vaccine Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Intranasal Vaccine Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Intranasal Vaccine Production (2018-2029) & (K Units)
Figure 5. World Intranasal Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 6. World Intranasal Vaccine Production Value Market Share by Region (2018-2029)
Figure 7. World Intranasal Vaccine Production Market Share by Region (2018-2029)
Figure 8. North America Intranasal Vaccine Production (2018-2029) & (K Units)
Figure 9. Europe Intranasal Vaccine Production (2018-2029) & (K Units)
Figure 10. China Intranasal Vaccine Production (2018-2029) & (K Units)
Figure 11. Japan Intranasal Vaccine Production (2018-2029) & (K Units)
Figure 12. Intranasal Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Intranasal Vaccine Consumption (2018-2029) & (K Units)
Figure 15. World Intranasal Vaccine Consumption Market Share by Region (2018-2029)
Figure 16. United States Intranasal Vaccine Consumption (2018-2029) & (K Units)
Figure 17. China Intranasal Vaccine Consumption (2018-2029) & (K Units)
Figure 18. Europe Intranasal Vaccine Consumption (2018-2029) & (K Units)
Figure 19. Japan Intranasal Vaccine Consumption (2018-2029) & (K Units)
Figure 20. South Korea Intranasal Vaccine Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Intranasal Vaccine Consumption (2018-2029) & (K Units)
Figure 22. India Intranasal Vaccine Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Intranasal Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Intranasal Vaccine Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Intranasal Vaccine Markets in 2022
Figure 26. United States VS China: Intranasal Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Intranasal Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Intranasal Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Intranasal Vaccine Production Market Share 2022
Figure 30. China Based Manufacturers Intranasal Vaccine Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Intranasal Vaccine Production Market Share 2022
Figure 32. World Intranasal Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Intranasal Vaccine Production Value Market Share by Type in 2022
Figure 34. Flu Vaccine
Figure 35. COVID-19 Vaccines
Figure 36. World Intranasal Vaccine Production Market Share by Type (2018-2029)
Figure 37. World Intranasal Vaccine Production Value Market Share by Type (2018-2029)
Figure 38. World Intranasal Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Intranasal Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Intranasal Vaccine Production Value Market Share by Application in 2022
Figure 41. Hospital
Figure 42. Clinic
Figure 43. World Intranasal Vaccine Production Market Share by Application (2018-2029)
Figure 44. World Intranasal Vaccine Production Value Market Share by Application (2018-2029)
Figure 45. World Intranasal Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 46. Intranasal Vaccine Industry Chain
Figure 47. Intranasal Vaccine Procurement Model
Figure 48. Intranasal Vaccine Sales Model
Figure 49. Intranasal Vaccine Sales Channels, Direct Sales, and Distribution
Figure 50. Methodology
Figure 51. Research Process and Data Source


More Publications